Form 4: Carlsmed CFO Leonard Greenstein Granted 71,429 Stock Options

Carlsmed, Inc.'s CFO and Treasurer, Leonard M. Greenstein, was granted 71,429 stock options with a $15 exercise price, vesting quarterly over four years.

Summary

• Leonard M. Greenstein, CFO and Treasurer of Carlsmed, Inc. (CARL), was granted 71,429 stock options.
• The stock options have an exercise price of $15 per share.
• The grant date for these options was July 22, 2025.
• The options will begin to vest in equal installments on each quarterly anniversary of the July 22, 2025, grant date.
• Full vesting of all stock options will occur on the fourth anniversary of the grant date, contingent upon continuous service by Mr. Greenstein.
• The expiration date for these stock options is July 9, 2035.
• Following this transaction, Mr. Greenstein beneficially owns a total of 155,102 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates the retention and incentivization of a key executive, which is generally viewed favorably for corporate stability and long-term performance. It is not highly impactful on its own.

Positives

• The grant of stock options aligns the interests of the CFO with those of the shareholders, incentivizing long-term performance.
• This compensation package helps in the retention of key executive talent.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of executive compensation, common across all industries for publicly traded companies, reflecting standard practices for incentivizing and retaining senior management.

Related Party Transactions

• The grant of stock options to Leonard M. Greenstein, the CFO and Treasurer, constitutes a transaction with a related party (an executive officer).

Stakeholder Impact

• Shareholders: Potential future dilution if options are exercised, but also benefit from incentivized management performance.
• Employees: Reflects standard executive compensation practices within the company.

Next Steps

• The granted stock options will vest in equal quarterly installments over the next four years, starting from July 22, 2025.

Key Dates

Keywords

Carlsmed, CARL, Stock Options, Executive Compensation, Form 4, Insider Transaction, Leonard Greenstein, CFO, Equity Grant